1. Home
  2. CTMX vs SHIM Comparison

CTMX vs SHIM Comparison

Compare CTMX & SHIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • SHIM
  • Stock Information
  • Founded
  • CTMX 2008
  • SHIM 1990
  • Country
  • CTMX United States
  • SHIM United States
  • Employees
  • CTMX N/A
  • SHIM N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • SHIM
  • Sector
  • CTMX Health Care
  • SHIM
  • Exchange
  • CTMX Nasdaq
  • SHIM Nasdaq
  • Market Cap
  • CTMX 444.3M
  • SHIM 53.7M
  • IPO Year
  • CTMX 2015
  • SHIM 2023
  • Fundamental
  • Price
  • CTMX $2.36
  • SHIM $2.06
  • Analyst Decision
  • CTMX Strong Buy
  • SHIM Hold
  • Analyst Count
  • CTMX 2
  • SHIM 2
  • Target Price
  • CTMX $5.00
  • SHIM $3.00
  • AVG Volume (30 Days)
  • CTMX 2.7M
  • SHIM 20.8K
  • Earning Date
  • CTMX 08-07-2025
  • SHIM 08-14-2025
  • Dividend Yield
  • CTMX N/A
  • SHIM N/A
  • EPS Growth
  • CTMX 128.27
  • SHIM N/A
  • EPS
  • CTMX 0.49
  • SHIM N/A
  • Revenue
  • CTMX $147,557,000.00
  • SHIM $482,303,000.00
  • Revenue This Year
  • CTMX N/A
  • SHIM $1.12
  • Revenue Next Year
  • CTMX N/A
  • SHIM $7.50
  • P/E Ratio
  • CTMX $4.86
  • SHIM N/A
  • Revenue Growth
  • CTMX 23.81
  • SHIM N/A
  • 52 Week Low
  • CTMX $0.40
  • SHIM $1.30
  • 52 Week High
  • CTMX $3.10
  • SHIM $4.94
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 53.34
  • SHIM 59.38
  • Support Level
  • CTMX $2.08
  • SHIM $1.55
  • Resistance Level
  • CTMX $2.44
  • SHIM $1.82
  • Average True Range (ATR)
  • CTMX 0.24
  • SHIM 0.17
  • MACD
  • CTMX -0.06
  • SHIM 0.02
  • Stochastic Oscillator
  • CTMX 27.94
  • SHIM 85.37

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About SHIM Shimmick Corporation

Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

Share on Social Networks: